2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
1Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich,
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …
2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary
The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …
atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for …
[HTML][HTML] Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation
VY Reddy, EP Gerstenfeld, A Natale… - … England Journal of …, 2023 - Mass Medical Soc
Background Catheter-based pulmonary vein isolation is an effective treatment for
paroxysmal atrial fibrillation. Pulsed field ablation, which delivers microsecond high-voltage …
paroxysmal atrial fibrillation. Pulsed field ablation, which delivers microsecond high-voltage …
Effect of catheter ablation using pulmonary vein isolation with vs without posterior left atrial wall isolation on atrial arrhythmia recurrence in patients with persistent …
Importance Pulmonary vein isolation (PVI) alone is less effective in patients with persistent
atrial fibrillation (AF) compared with paroxysmal AF. The left atrial posterior wall may …
atrial fibrillation (AF) compared with paroxysmal AF. The left atrial posterior wall may …
2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart …
JA Joglar, MK Chung, AL Armbruster, EJ Benjamin… - Circulation, 2024 - Am Heart Assoc
AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery …
G Hindricks, T Potpara, N Dagres, E Arbelo… - European heart …, 2021 - academic.oup.com
MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease: the Task Force on sports cardiology and exercise in patients with …
or therapeutic medical strategies. However, the ESC Guidelines do not override in any way
whatsoever the individual responsibility of health professionals to make appropriate and …
whatsoever the individual responsibility of health professionals to make appropriate and …
Effect of MRI-guided fibrosis ablation vs conventional catheter ablation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the DECAAF II …
Importance Ablation of persistent atrial fibrillation (AF) remains a challenge. Left atrial
fibrosis plays an important role in the pathophysiology of AF and has been associated with …
fibrosis plays an important role in the pathophysiology of AF and has been associated with …
Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial
DL Packer, JP Piccini, KH Monahan, HR Al-Khalidi… - Circulation, 2021 - Am Heart Assoc
Background: In patients with heart failure and atrial fibrillation (AF), several clinical trials
have reported improved outcomes, including freedom from AF recurrence, quality of life, and …
have reported improved outcomes, including freedom from AF recurrence, quality of life, and …
JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias
A Nogami, T Kurita, H Abe, K Ando, T Ishikawa… - Circulation …, 2021 - jstage.jst.go.jp
Pacemaker treatment for bradyarrhythmia was first approved for national health insurance
coverage in Japan in 1974, and its use rapidly became widespread thereafter …
coverage in Japan in 1974, and its use rapidly became widespread thereafter …